Skip to content

Earnings Screener Charts Portfolio Pricing

Connect your AI

Stocks
Crinetics Pharmaceuticals
Business Segments
Business Segments

Business Segments18 metrics

Total Revenue Cost of product revenue Expenses Related To Paltusotine Expenses Related To Atumelnant Early Research and Development Programs Research And Development Personnel Expenses Research And Development Stock Based Compensation Other Research and Development Expense R&D External Selling, General And Administrative Expenses Commercial Selling, General And Administrative Personnel Expenses Selling, General And Administrative Stock Based Compensation Selling, General and Administrative Expense Total other income, net Net loss Other Research and Development Programs Income Tax Loss on equity method investment

Explore

Earnings Calendar
Stock Screener
Metrics Screener
Charts
Watchlist
Portfolio

Resources

Pricing
Releases
About
Contact
Methodology
Cite & Reuse
Sign in / Sign up

Connect

Claude
Claude Code
ChatGPT
Codex
Codex CLI
Cursor
Other clients

Legal

Privacy Policy
Terms of Service
Cookie Policy
SEC EDGAR
support@opencapital.sh

© 2026 OpenCapital. All rights reserved.

Data sourced from SEC filings — methodology

OpenCapital is not affiliated with or endorsed by the U.S. Securities and Exchange Commission (SEC). All data is sourced from publicly available SEC filings.